Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus


  • Benhur Joel Shadrach Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Rishabh Goel | Department of Pulmonary Medicine, Shahi Global Hospital, Gorakhpur, India.
  • Kunal Deokar Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
  • Anukool Jain Department of Pulmonary Medicine, Pushpanjali Hospital, Agra, India.


Dear Editor,

A 55-year-female, house wife, non-smoker, morbidly obese (BMI>35) with no other co-morbidities or pre-existing lung disease presented to the emergency room with complaints of highgrade fever, cough with minimal sputum, progressive breathlessness, streaky haemoptysis, and anorexia for the past 5 days. She was admitted in intensive care unit (ICU) for severe COVID-19 pneumonia three months back and had successfully recovered after 24 days of hospitalization....



PlumX Metrics


Download data is not yet available.


Franquet T, Müller NL, Giménez A, et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001;21:825-37. DOI:

Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-74. DOI:

Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018;6:782-92. DOI:

Prattes J, Valentin T, Hoenigl M, et al. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. Med Mycol Case Rep 2020;31:2-5. DOI:

Helleberg M, Steensen M, Arendrup MC. Invasive aspergillosis in patients with severe COVID-19 pneumonia. Clin Microbiol Infect 2020;27:147-8. DOI:

van Arkel ALE, Rijpstra TA, Belderbos HNA, et al. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med 2020;202:132-5. DOI:

Rutsaert L, Steinfort N, Van Hunsel T, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care 2020;10:71. DOI:

Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA) - From immunology to treatment. J Fungi (Basel) 2020;6:91. DOI:

Armstrong-James D, Youngs J, Bicanic T, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J 2020;56:2002554. DOI:

Patterson TF, Thompson GR 3rd, Denning DW, et al. practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016;63:e1-e60. DOI:


COVID-19 - Collection of articles on the Coronavirus outbreak
Supporting Agencies
IPA, COVID-19, CAPA, Infective sequalae, bronchoalveolar lavage
  • Abstract views: 614

  • PDF: 279
How to Cite
Shadrach, Benhur Joel, Rishabh Goel, Kunal Deokar, and Anukool Jain. 2021. “Invasive Pulmonary Aspergillosis in a COVID-19 Recovered Patient: Unravelling an Infective Sequalae of the SARS-CoV-2 Virus”. Monaldi Archives for Chest Disease 91 (2).